510(k) K872078
K872078 is an FDA 510(k) premarket notification submitted by Solomon Park Research Laboratories for the device "QC3 WHOLE HUMAN SERUM, HDL-CHOLESTEROL CONTROL". The FDA issued a decision of Substantially Equivalent on June 18, 1987. The device falls under product code DER (Alpha-1-Lipoprotein, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5580.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 18, 1987
- Date Received
- May 29, 1987
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Alpha-1-Lipoprotein, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5580
- Review Panel
- IM
- Submission Type